Reckitt Benckiser Group plc (3RB.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
71.88-0.72 (-0.99%)
At close: 5:35PM CET
| Previous close | 72.60 |
| Open | 72.12 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 5000 |
| Day's range | 71.30 - 72.12 |
| 52-week range | 58.68 - 89.08 |
| Volume | 12,091 |
| Avg. volume | 9,888 |
| Market cap | 50.355B |
| Beta (5Y monthly) | 0.12 |
| PE ratio (TTM) | 5.92 |
| EPS (TTM) | 12.15 |
| Earnings date | N/A |
| Forward dividend & yield | 1.94 (2.67%) |
| Ex-dividend date | 20 Aug 2020 |
| 1y target est | N/A |
- Yahoo Finance UK
UBS predicts UK stock market and pound rally in 2021
Analysts at UBS say the outlook for UK equities has never been brighter.
- Simply Wall St.
Reckitt Benckiser Group plc (LON:RB.) Insiders Increased Their Holdings
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
- Reuters
Indivior to 'vigorously defend' Reckitt Benckiser's $1.4 billion claim
The company "Strongly believes that the claim is without merit and that it has strong grounds for defending against the claim should it be served," said Indivior, which was spun off from Reckitt in 2014. Indivior said that the claim has not been served yet. Last week, the British drugmaker disclosed that Reckitt had submitted a 1.07 billion pound claim earlier this month to the Commercial Court in London against Indivior relating to their demerger agreement.
© 2021 Verizon Media. All rights reserved.
